BOEHRINGER INGELHEIM INTERNATIONAL GMBH - 27 Jun 2023 Form 3 Insider Report for Minerva Neurosciences, Inc. (NERV)

Role
10%+ Owner
Signature
/s/ Christoph Gauger, Registered Manager (Prokurist), the GP, /s/ Martin Bergmann, Registered Manager (Prokurist), the GP
Issuer symbol
NERV
Transactions as of
27 Jun 2023
Net transactions value
$0
Form type
3
Filing time
07 Jul 2023, 16:15:10 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NERV Common Stock 1,275,000 27 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NERV Pre-Funded Warrant (right to buy) 27 Jun 2023 Common Stock 225,225 $0.0100 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held directly by Boehringer Ingelheim International GmbH ("International GmbH"), a wholly owned indirect subsidiary of C. H. Boehringer Sohn AG & Co. KG ("Parent"). Boehringer AG (the "GP") is the General Partner of Parent. Under Securities and Exchange Commission rules and regulations, the GP may be deemed to have indirect beneficial ownership of the shares held by International GmbH.
F2 The Pre-Funded Warrant will not expire until exercised in full.